FilingSEC EDGAR6-K
Clinuvel Presents Positive Patient Cases from CUV105 Vitiligo Trial
· SEC accepted
Filing content
Clinuvel presented interim patient cases from the CUV105 trial, demonstrating clinical response to SCENESSE® combined with phototherapy in vitiligo patients, at the EADV conference.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…